On the cover of the 10 November 2022 issue (volume 140, issue 19), “Phase 1 trial of pyruvate kinase inhibitor mitapivat in sickle cell disease” should read “Phase 1 trial of pyruvate kinase activator mitapivat in sickle cell disease.”

Sign in via your Institution